Teva To Sue FDA Over Pravachol Marketing Exclusivity
Israeli drug maker Teva Pharmaceutical Industries Ltd. said Wednesday it would sue the U.S. Food and Drug Administration over a decision that effectively wiped out the company's marketing exclusivity for a...To view the full article, register now.
Already a subscriber? Click here to view full article